Embed Size (px)
Citation preview
B52347
FILED 03/21/2019
Government Auditing Standards
Code of Federal Regulations Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards
GOVERNMENT AUDITING STANDARDS
Government Auditing Standards
Government Auditing Standards
-4-
GOVERNMENT AUDITING STANDARDS
Government Auditing Standards
Government Auditing Standards
-5-
OMB Compliance Supplement
Management's Responsibility
Auditor's Responsibility
Government Auditing StandardsCode of Federal
Regulations Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards
Opinion on Each Major Federal Program
Other Matters
-8-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Dire
ct P
rogr
ams
by C
FDA
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
-10-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
Tota
l C
FDA
No.
10.0
01
174,
972
-
-
-
-
-
174,
972
-
*
**
In D
epar
tmen
t Of N
atur
al R
esou
rces
Tot
al10
0,69
6
-
-
-
-
-
10
0,69
6
-
*
**
Xav
ier U
nive
rsity
Tot
al35
,860
-
-
-
-
-
35
,860
-
Tota
l C
FDA
No.
10.0
25
136,
556
-
-
-
-
-
136,
556
-
-11-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
In S
tate
Dep
artm
ent O
f Agr
icul
ture
Tot
al19
6,50
4
-
-
-
-
-
19
6,50
4
-
Tota
l C
FDA
No.
10.1
70
208,
101
-
-
-
-
-
208,
101
-
Tota
l C
FDA
No.
10.1
71
750
-
-
-
-
-
75
0
-
*
**
Iow
a S
tate
Uni
vers
ity T
otal
12,7
86
-
-
-
-
-
12,7
86
-
Tota
l C
FDA
No.
10.2
00
17,1
98
-
-
-
-
-
17,1
98
-
Tota
l C
FDA
No.
10.2
02
(24)
-
-
-
-
-
(2
4)
-
Tota
l C
FDA
No.
10.2
12
17,7
63
-
-
-
-
-
17,7
63
-
*
**
Uni
vers
ity O
f Min
neso
ta T
otal
144,
226
-
-
-
99,0
15
-
24
3,24
1
-
Tota
l C
FDA
No.
10.2
15
144,
226
-
-
-
99,0
15
-
24
3,24
1
-
-12-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
10.2
17
364
-
-
-
44
,207
-
44,5
71
-
Tota
l C
FDA
No.
10.2
19
1,46
3
-
-
-
-
-
1,
463
-
Tota
l C
FDA
No.
10.3
03
115,
060
-
-
-
-
-
115,
060
-
Tota
l C
FDA
No.
10.3
04
52,8
71
-
-
-
-
-
52,8
71
-
Tota
l C
FDA
No.
10.3
07
47,2
92
-
-
-
-
-
47,2
92
-
Tota
l C
FDA
No.
10.3
09
47,9
36
-
-
-
-
-
47,9
36
-
*
**
Agr
icul
tura
l Res
earc
h S
ervi
ce T
otal
53,6
95
-
-
-
-
-
53,6
95
-
*
**
Kan
sas
Sta
te U
nive
rsity
Tot
al10
8,47
8
-
-
-
-
-
10
8,47
8
-
-13-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
10.3
10
535,
223
-
-
-
45,7
41
-
58
0,96
4
-
Tota
l C
FDA
No.
10.3
11
-
-
-
-
16
,507
-
16,5
07
-
Tota
l C
FDA
No.
10.3
29
4,53
7
-
-
-
-
-
4,
537
-
*
**
Mis
siss
ippi
Sta
te U
nive
rsity
Tot
al28
,889
-
-
-
19
,716
-
48,6
05
-
Tota
l C
FDA
No.
10.3
52
28,8
89
-
-
-
19,7
16
-
48
,605
-
*
**
Nat
iona
l Ins
t of F
ood
& A
gric
ultu
re T
otal
-
-
-
-
1,
209,
112
-
1,20
9,11
2
-
*
**
Uni
vers
ity O
f Min
neso
ta T
otal
-
-
-
-
26
,263
-
26,2
63
-
*
**
Uni
vers
ity O
f Neb
rask
a-Li
ncol
n T
otal
29,2
23
-
-
-
229
-
29,4
52
-
Tota
l C
FDA
No.
10.5
00
73,2
24
-
-
-
1,29
5,89
7
-
1,
369,
121
-
-14-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
10.5
59
-
-
-
-
8,
743
-
8,
743
-
Tot
al C
hild
Nut
ritio
n C
lust
er
-
-
-
-
8
,743
-
8,74
3
-
*
**
In F
amily
& S
ocia
l Ser
vice
s A
dmin
Tot
al-
-
-
-
7,17
7,90
6
-
7,
177,
906
-
Tota
l C
FDA
No.
10.5
61
-
-
-
-
7,
177,
906
-
7,17
7,90
6
-
Tot
al S
NA
P C
lust
er
-
-
-
-
7,
177,
906
-
7,1
77,9
06
-
Tota
l C
FDA
No.
10.6
52
49,6
08
-
-
-
-
-
49,6
08
-
Tota
l C
FDA
No.
10.8
90
26,0
89
-
-
-
-
-
26,0
89
-
Tota
l C
FDA
No.
10.9
02
207,
770
-
-
-
-
-
207,
770
-
Tota
l C
FDA
No.
10.9
12
-
-
-
-
10
3,01
0
-
103,
010
-
-15-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
P3
Nan
o T
otal
256,
110
40,6
91
-
-
-
-
25
6,11
0
40
,691
Tota
l C
FDA
No.
10.R
D
25
6,11
0
40
,691
-
-
-
-
256,
110
40,6
91
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Dep
artm
ent o
f Agr
icul
ture
Dire
ct P
rogr
ams
by C
FDA
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
*
**
Uni
v O
f Illi
nois
At C
ham
paig
n-U
rban
a T
otal
210,
365
81,5
26
-
-
-
-
21
0,36
5
81
,526
*
**
Uni
vers
ity O
f Illi
nois
Tot
al4,
683
-
-
-
515,
602
-
52
0,28
5
-
Tota
l C
FDA
No.
11.
417
21
5,04
8
81
,526
-
-
515,
758
-
73
0,80
6
81
,526
-16-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
In D
epar
tmen
t Of N
atur
al R
esou
rces
Tot
al11
,513
-
-
-
-
-
11
,513
-
Tota
l C
FDA
No.
11.
419
11
,513
-
-
-
-
-
11
,513
-
Tota
l C
FDA
No.
11.
432
-
-
-
-
45,6
66
-
45
,666
-
Tota
l C
FDA
No.
11.
609
22
6,29
0
-
-
-
-
-
22
6,29
0
-
Tota
l C
FDA
No.
11.
611
28
5,11
8
-
-
-
-
-
28
5,11
8
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Dep
artm
ent o
f Com
mer
ce
Dire
ct P
rogr
ams
by C
FDA
12.3
00B
asic
and
App
lied
Sci
entif
ic R
esea
rch
-
12.3
51B
asic
Sci
entif
ic R
esea
rch
- C
omba
ting
Wea
pons
of M
ass
Des
truct
ion
-
12.8
00A
ir Fo
rce
Def
ense
Res
earc
h S
cien
ces
Pro
gram
-
12.9
10R
esea
rch
and
Tech
nolo
gy D
evel
opm
ent
-
12.R
DU
.S. D
epar
tmen
t of D
efen
se17
1224
44
FA86
51-1
6-F-
1010
FA87
50-1
7-C
-006
9
*
**
12.R
D T
otal
649,
691
34,9
42
-
-
-
-
64
9,69
1
34
,942
12.U
06U
.S. D
epar
tmen
t of D
efen
seS
HA
NN
ON
DA
ILY
Tota
l Dire
ct P
rogr
ams
-17-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Pas
s-Th
roug
h G
rant
ors
by C
FDA
*
**
Uni
vers
ity O
f Cal
iforn
ia-R
iver
side
Tot
al14
8,57
2
-
-
-
-
-
14
8,57
2
-
Tota
l C
FDA
No.
12.
800
1,
688,
871
-
-
-
-
-
1,
688,
871
-
*
**
CFD
Res
earc
h C
orpo
ratio
n T
otal
164,
320
-
-
-
-
-
164,
320
-
-18-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
Leid
os T
otal
40,1
26
-
-
-
-
-
40,1
26
-
*
**
Spe
ctra
l Ene
rgie
s, L
LC T
otal
278,
504
-
-
-
-
-
278,
504
-
*
**
UE
S In
c. T
otal
71,3
29
-
-
-
-
-
71,3
29
-
*
**
Uni
vers
al T
echn
olog
y C
orpo
ratio
n T
otal
52,0
81
-
-
-
-
-
52,0
81
-
Tota
l C
FDA
No.
12.
RD
1,11
6,48
6
23,8
11
-
-
-
-
1,
116,
486
23
,811
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Air
Forc
e
Dire
ct P
rogr
ams
by C
FDA
12.4
20M
ilita
ry M
edic
al R
esea
rch
and
Dev
elop
men
t-
12.4
31B
asic
Sci
entif
ic R
esea
rch
-
12.6
30B
asic
, App
lied,
and
Adv
ance
d R
esea
rch
in S
cien
ce a
nd E
ngin
eerin
g-
12.R
DU
.S. D
epar
tmen
t of D
efen
se15
0332
25
W81
XW
H-1
4-1-
0588
W91
1NF-
16-2
-002
0
W91
1NF-
18-1
-007
4
-19-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
W91
2HQ
-14-
C-0
047
W91
2HQ
-16-
C-0
048
W91
2HQ
-18-
C-0
021
W91
CR
B-1
4-C
-002
5
*
**
12.R
D T
otal
2,76
5,59
6
10,2
23
-
-
-
-
2,
765,
596
10
,223
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
Tota
l C
FDA
No.
12.
420
76
,916
-
-
-
-
-
76
,916
-
Tota
l C
FDA
No.
12.
431
83
6,47
5
61
,235
-
-
-
-
836,
475
61,2
35
-20-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
Uni
vers
ity O
f Del
awar
e T
otal
76,9
96
-
-
-
-
-
76,9
96
-
Tota
l C
FDA
No.
12.
630
76
,996
-
-
-
-
-
76
,996
-
*
**
Ibm
Tot
al25
3,69
9
-
-
-
-
-
25
3,69
9
-
*
**
Son
risa
Res
earc
h In
c T
otal
760,
173
-
-
-
-
-
760,
173
-
Tota
l C
FDA
No.
12.
RD
1,61
9,28
0
249,
618
-
-
-
-
1,
619,
280
24
9,61
8
Tota
l C
FDA
No.
12.
U01
-
-
-
-
276
-
276
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Arm
y
Dire
ct P
rogr
ams
by C
FDA
12.9
10R
esea
rch
and
Tech
nolo
gy D
evel
opm
ent
-
12.R
DU
.S. D
epar
tmen
t of D
efen
seH
R00
11-1
3-2-
0010
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
Tota
l C
FDA
No.
12.
431
48
,559
-
-
-
-
-
48
,559
-
-21-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
12.
910
75
4,86
3
-
-
-
-
-
75
4,86
3
-
Tota
l C
FDA
No.
12.
RD
2,90
4,36
5
-
-
-
-
-
2,90
4,36
5
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Def
ense
Adv
ance
d R
esea
rch
Proj
ects
Age
ncy
Dire
ct P
rogr
ams
by C
FDA
12.3
00B
asic
and
App
lied
Sci
entif
ic R
esea
rch
-
12.3
51B
asic
Sci
entif
ic R
esea
rch
- C
omba
ting
Wea
pons
of M
ass
Des
truct
ion
-
12.4
20M
ilita
ry M
edic
al R
esea
rch
and
Dev
elop
men
t-
12.9
10R
esea
rch
and
Tech
nolo
gy D
evel
opm
ent
-
12.R
DU
.S. D
epar
tmen
t of D
efen
se16
-014
1706
6836
N41
756-
14-C
-329
2
N68
936-
17-P
-001
0
N68
9361
8P00
78
*
**
12.R
D T
otal
345,
989
-
-
-
-
-
345,
989
-
12.U
04U
.S. D
epar
tmen
t of D
efen
seN
0018
9-16
-P-Z
208
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
-22-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
12.
300
73
0,79
2
-
-
-
-
-
73
0,79
2
-
Tota
l C
FDA
No.
12.
RD
1,56
5,65
8
-
-
-
-
-
1,56
5,65
8
-
Tota
l C
FDA
No.
12.
U02
-
-
-
-
89,9
15
-
89
,915
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Nav
y
Dire
ct P
rogr
ams
by C
FDA
12.3
00B
asic
and
App
lied
Sci
entif
ic R
esea
rch
-
12.3
51B
asic
Sci
entif
ic R
esea
rch
- C
omba
ting
Wea
pons
of M
ass
Des
truct
ion
-
12.9
01M
athe
mat
ical
Sci
ence
s G
rant
s P
rogr
am-
-23-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
12.9
02In
form
atio
n S
ecur
ity G
rant
s-
12.9
03G
enC
yber
Gra
nts
Pro
gram
-
12.9
05C
yber
Sec
urity
Cor
e C
urric
ulum
-
12.9
10R
esea
rch
and
Tech
nolo
gy D
evel
opm
ent
-
12.R
DU
.S. D
epar
tmen
t of D
efen
se17
1117
66
2102
738-
03
2102
765-
02
HQ
0147
-15-
C-6
003
HQ
0147
-15-
C-6
009
HQ
0147
-16-
C-6
001
HQ
0147
-16-
C-6
005
N00
174-
16-C
-000
7
NTP
1711
1432
SP
8000
-18-
P-0
007
*
**
12.R
D T
otal
1,54
5,83
8
-
-
-
-
-
1,54
5,83
8
-
12.U
00U
.S. D
epar
tmen
t of D
efen
seP
.O.7
1428
9
12.U
03U
.S. D
epar
tmen
t of D
efen
seIP
A M
ELI
SS
A D
AR
K
12.U
05U
.S. D
epar
tmen
t of D
efen
seIP
A17
0124
97
12.U
08U
.S. D
epar
tmen
t of D
efen
se74
0-00
7-26
7
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
Tota
l C
FDA
No.
12.
351
11
,497
-
-
-
-
-
11
,497
-
Tota
l C
FDA
No.
12.
611
20
4,96
6
-
-
-
67
6,15
1
-
881,
117
-
Tota
l C
FDA
No.
12.
630
25
,947
-
-
-
-
-
25
,947
-
Tota
l C
FDA
No.
12.
750
76
,947
-
-
-
-
-
76
,947
-
-24-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
12.
800
25
9,76
5
18
6,50
3
-
-
-
-
259,
765
186,
503
*
**
App
lied
Res
earc
h A
ssoc
iate
s, In
c T
otal
394,
818
-
-
-
-
-
394,
818
-
*
**
Ste
vens
Inst
itute
Of T
echn
olog
y T
otal
17,1
88
-
-
-
-
-
17,1
88
-
Tota
l C
FDA
No.
12.
RD
1,67
3,96
5
(37,
500)
-
-
-
-
1,
673,
965
(3
7,50
0)
Tota
l C
FDA
No.
12.
U07
-
-
-
-
3,35
2
-
3,35
2
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Oth
er D
OD
Age
ncie
s
Tota
l Dep
artm
ent o
f Def
ense
Dire
ct P
rogr
ams
Tota
l Dep
artm
ent o
f Def
ense
Pas
s-Th
roug
h G
rant
ors
-25-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l Dep
artm
ent o
f Def
ense
Dire
ct P
rogr
ams
by C
FDA
Tota
l Dire
ct P
rogr
ams
Tota
l Hou
sing
and
Urb
an D
evel
opm
ent
Dire
ct P
rogr
ams
by C
FDA
*
**
15.R
D T
otal
65,7
77
-
-
-
-
-
65,7
77
-
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
Tota
l C
FDA
No.
15.
608
45
,970
-
-
-
-
-
45
,970
-
-26-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
15.
611
12
,531
-
-
-
-
-
12
,531
-
Tot
al F
ish
and
Wild
life
Clu
ster
12,5
31
-
-
-
-
-
12,
531
-
Tota
l C
FDA
No.
15.
615
20
,979
-
-
-
-
-
20
,979
-
*
**
In D
epar
tmen
t Of N
atur
al R
esou
rces
Tot
al37
,319
-
-
-
-
-
37
,319
-
Tota
l C
FDA
No.
15.
634
96
,303
-
-
-
-
-
96
,303
-
Tota
l C
FDA
No.
15.
805
37
6,69
5
-
-
-
-
-
37
6,69
5
-
Tota
l C
FDA
No.
15.
815
6,
691
3,00
0
-
-
-
-
6,69
1
3,00
0
Tota
l C
FDA
No.
15.
RD
113,
728
-
-
-
-
-
113,
728
-
Tota
l C
FDA
No.
15.
U00
-
-
-
-
10,1
11
-
10
,111
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Dep
artm
ent o
f Int
erio
r
Dire
ct P
rogr
ams
by C
FDA
-27-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
Tota
l C
FDA
No.
16.
300
-
-
-
-
240,
000
-
24
0,00
0
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Dep
artm
ent o
f Jus
tice
Dire
ct P
rogr
ams
by C
FDA
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
Tota
l C
FDA
No.
17.
502
44
,236
-
-
-
-
-
44
,236
-
Tota
l C
FDA
No.
17.
U00
-
-
-
-
30,3
96
-
30
,396
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Dep
artm
ent o
f Lab
or
Dire
ct P
rogr
ams
by C
FDA
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
Tota
l C
FDA
No.
19.
009
16
,682
-
-
-
-
-
16
,682
-
-28-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
Inst
itute
Of I
nter
natio
nal E
duca
tion
Tot
al-
-
-
-
21,3
02
-
21
,302
-
Tota
l C
FDA
No.
19.
401
-
-
-
-
21,3
02
-
21
,302
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Dep
artm
ent o
f Sta
te
Dire
ct P
rogr
ams
by C
FDA
Tot
al H
ighw
ay P
lann
ing
and
Con
stru
ctio
n C
lust
er
52
,642
-
-
-
-
-
5
2,64
2
-
*
**
20.R
D T
otal
61,4
04
-
-
-
-
-
61,4
04
-
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
-29-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
-30-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
-31-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
-32-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
-33-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
In D
epar
tmen
t Of T
rans
porta
tion
Tot
al7,
104,
948
22
1,46
0
-
-
16,1
91
-
7,
121,
139
22
1,46
0
Tota
l C
FDA
No.
20.
200
7,
118,
930
22
1,46
0
-
-
16,1
91
-
7,
135,
121
22
1,46
0
*
**
In C
rimin
al J
ustic
e In
stitu
te T
otal
111,
645
-
-
-
-
-
111,
645
-
Tota
l C
FDA
No.
20.
601
11
1,64
5
-
-
-
-
-
11
1,64
5
-
Tot
al H
ighw
ay S
afet
y C
lust
er
111
,645
-
-
-
-
-
111
,645
-
Tota
l C
FDA
No.
20.
701
29
6,01
9
-
-
-
-
-
29
6,01
9
-
Tota
l C
FDA
No.
20.
RD
88,8
51
-
-
-
-
-
88,8
51
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Dep
artm
ent o
f Tra
nspo
rtat
ion
Dire
ct P
rogr
ams
by C
FDA
-34-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
43.R
D T
otal
256,
738
7,83
7
-
-
-
-
256,
738
7,83
7
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
*
**
Ana
lytic
al M
echa
nics
Ass
oc, I
nc T
otal
10,8
01
-
-
-
-
-
10,8
01
-
Tota
l C
FDA
No.
43.
001
27
4,13
7
-
-
-
-
-
27
4,13
7
-
-35-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
43.
002
51
,239
-
-
-
-
-
51
,239
-
*
**
Jet P
ropu
lsio
n La
bora
tory
Tot
al12
6,91
3
-
-
-
-
-
12
6,91
3
-
*
**
Phy
sica
l Sci
ence
s, In
c T
otal
82,2
76
-
-
-
-
-
82,2
76
-
Tota
l C
FDA
No.
43.
RD
875,
730
-
-
-
-
-
875,
730
-
Tota
l C
FDA
No.
43.
U01
-
-
-
-
68,0
95
-
68
,095
-
Tota
l Pas
s-Th
roug
h G
rant
ors
-36-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l Nat
iona
l Aer
onau
tics
and
Spac
e A
dmin
istr
atio
n
Dire
ct P
rogr
ams
by C
FDA
Tota
l Dire
ct P
rogr
ams
Tota
l Nat
iona
l End
owm
ent o
f the
Art
s an
d H
uman
ities
Dire
ct P
rogr
ams
by C
FDA
*
**
47.R
D T
otal
88,6
01
-
-
-
-
-
88,6
01
-
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
-37-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
Rut
gers
, The
Sta
te U
nive
rsity
Tot
al14
2,66
5
-
-
-
-
-
14
2,66
5
-
Tota
l C
FDA
No.
47.
041
91
3,45
5
-
-
-
-
-
91
3,45
5
-
*
**
Prin
ceto
n U
nive
rsity
Tot
al68
8,11
4
-
-
-
-
-
68
8,11
4
-
-38-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
47.
049
90
7,08
9
-
-
-
-
-
90
7,08
9
-
*
**
Col
umbi
a U
nive
rsity
Tot
al16
7,73
1
-
-
-
-
-
16
7,73
1
-
Tota
l C
FDA
No.
47.
050
21
5,96
6
-
-
-
-
-
21
5,96
6
-
Tota
l C
FDA
No.
47.
070
1,
145,
882
-
-
-
-
-
1,
145,
882
-
-39-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
Mic
higa
n S
tate
Uni
vers
ity T
otal
316,
596
-
-
-
-
-
316,
596
-
*
**
Virg
inia
Tec
h T
otal
13,7
41
-
-
-
-
-
13,7
41
-
Tota
l C
FDA
No.
47.
074
1,
159,
894
-
-
-
-
-
1,
159,
894
-
Tota
l C
FDA
No.
47.
075
12
3,23
2
-
-
-
-
-
12
3,23
2
-
*
**
Sin
clai
r Com
mun
ity C
olle
ge T
otal
18,7
75
-
-
-
-
-
18,7
75
-
-40-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
47.
076
1,
138,
396
-
-
-
-
-
1,
138,
396
-
Tota
l C
FDA
No.
47.
078
17
,079
-
-
-
-
-
17
,079
-
Tota
l C
FDA
No.
47.
079
69
,655
-
-
-
-
-
69
,655
-
Tota
l C
FDA
No.
47.
RD
101,
159
-
-
-
-
-
101,
159
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Nat
iona
l Sci
ence
Fou
ndat
ion
Pas
s-Th
roug
h G
rant
ors
by C
FDA
-41-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
Offi
ce o
f Sm
all B
usin
ess
& E
ntrs
hp T
otal
-
-
-
-
69
5,24
6
-
695,
246
-
Tota
l C
FDA
No.
59.
037
-
-
-
-
695,
246
-
69
5,24
6
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Sm
all B
usin
ess
Adm
inis
trat
ion
Dire
ct P
rogr
ams
by C
FDA
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
Tota
l C
FDA
No.
66.
436
-
-
-
-
8,34
9
-
8,34
9
-
*
**
In D
epar
tmen
t Of E
nviro
nmen
tal M
gmt
155,
818
-
-
-
9,05
1
-
164,
869
-
Tota
l C
FDA
No.
66.
460
15
5,81
8
-
-
-
9,
051
-
16
4,86
9
-
-42-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
66.
708
-
-
-
-
(364
)
-
(364
)
-
Tota
l C
FDA
No.
66.
951
26
-
-
-
-
-
26
-
*
**
Peg
asus
Tec
hnic
al S
ervi
ces
Inc
Tot
al82
,365
-
-
-
-
-
82
,365
-
Tota
l C
FDA
No.
66.
RD
96,8
89
-
-
-
-
-
96,8
89
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Env
ironm
enta
l Pro
tect
ion
Age
ncy
Dire
ct P
rogr
ams
by C
FDA
*
**
77.R
D T
otal
579,
412
406,
310
-
-
-
-
57
9,41
2
40
6,31
0
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
Tota
l C
FDA
No.
77.
009
75
,181
-
-
-
-
-
75
,181
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Nuc
lear
Reg
ulat
ory
Com
mis
sion
-43-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Dire
ct P
rogr
ams
by C
FDA
-44-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
81.R
D T
otal
5,26
2,41
6
39,9
12
-
-
-
-
5,
262,
416
39
,912
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
*
**
Sta
nfor
d U
nive
rsity
Tot
al22
3,58
7
-
-
-
13
-
223,
600
-
-45-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
81.
049
38
8,82
1
-
-
-
13
-
388,
834
-
*
**
Uni
vers
ity O
f Ten
ness
ee (T
he)
Tota
l1,
563,
216
-
-
-
-
-
1,
563,
216
-
Tota
l C
FDA
No.
81.
086
1,
711,
018
-
-
-
-
-
1,
711,
018
-
Tota
l C
FDA
No.
81.
087
21
5,34
7
-
-
-
-
-
21
5,34
7
-
Tota
l C
FDA
No.
81.
113
28
1,94
7
-
-
-
-
-
28
1,94
7
-
Tota
l C
FDA
No.
81.
121
34
5,78
5
-
-
-
-
-
34
5,78
5
-
Tota
l C
FDA
No.
81.
135
56
,207
-
-
-
-
-
56
,207
-
-46-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
Law
renc
e Li
verm
ore
Nat
iona
l Lab
orat
ory
Tot
al16
,830
-
-
-
-
-
16
,830
-
*
**
Oak
Rid
ge N
atio
nal L
abor
ator
y T
otal
101,
935
-
-
-
-
-
101,
935
-
*
**
Uni
vers
ity O
f Ten
ness
ee (T
he)
Tota
l72
7,89
0
-
-
-
-
-
72
7,89
0
-
Tota
l C
FDA
No.
81.
RD
1,87
5,92
0
-
-
-
-
-
1,87
5,92
0
-
Tota
l C
FDA
No.
81.
U04
-
-
-
-
117,
122
-
11
7,12
2
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Dep
artm
ent o
f Ene
rgy
Dire
ct P
rogr
ams
by C
FDA
-47-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tot
al T
rio C
lust
er
535
,047
-
-
-
2,
261,
426
-
2,7
96,4
73
-
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
Tota
l C
FDA
No.
84.
048
-
-
-
-
4,59
9
-
4,59
9
-
Tota
l C
FDA
No.
84.
116
5,
242
-
-
-
223,
429
-
22
8,67
1
-
Tota
l C
FDA
No.
84.
305
87
,281
-
-
-
-
-
87
,281
-
-48-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
In D
epar
tmen
t Of E
duca
tion
Tot
al12
8,68
4
-
-
-
53
8,53
9
9,57
7
667,
223
9,57
7
Tota
l C
FDA
No.
84.
366
12
8,68
4
-
-
-
53
8,53
9
9,57
7
667,
223
9,57
7
Tota
l C
FDA
No.
84.
367
85
,723
-
-
-
7,
055
-
92
,778
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Dep
artm
ent o
f Edu
catio
n
Dire
ct P
rogr
ams
by C
FDA
93.2
24C
onso
lidat
ed H
ealth
Cen
ters
(Com
mun
ity H
ealth
Cen
ters
, Mig
rant
H
ealth
Cen
ters
, H-
-
-
-
-
2,
264,
604
-
2,26
4,60
4
-
Tot
al H
ealth
Cen
ter P
rogr
am C
lust
er
-
-
-
-
2,
264,
604
-
2,2
64,6
04
-
93.2
26R
esea
rch
on H
ealth
care
Cos
ts, Q
ualit
y an
d O
utco
mes
-49
6,69
2
52
,970
-
-
-
-
496,
692
52,9
70
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
Tota
l C
FDA
No.
93.
217
-
-
-
-
127,
084
-
12
7,08
4
-
*
**
Indi
ana
Uni
vers
ity T
otal
75,5
87
-
-
-
-
-
75,5
87
-
Tota
l C
FDA
No.
93.
226
37
5,83
8
-
-
-
(2
,896
)
-
37
2,94
2
-
-49-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
93.
558
-
-
-
-
78,0
17
-
78
,017
-
Tot
al T
AN
F C
lust
er
-
-
-
-
78,
017
-
78,
017
-
Tota
l C
FDA
No.
93.
667
-
-
-
-
78,7
42
-
78
,742
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Age
ncy
for H
ealth
care
Res
earc
h an
d Q
ualit
y
Dire
ct P
rogr
ams
by C
FDA
93.2
62O
ccup
atio
nal S
afet
y an
d H
ealth
Pro
gram
-22
,225
-
-
-
61
,241
-
83,4
66
-
93.3
10Tr
ans-
NIH
Res
earc
h S
uppo
rt-
630,
740
-
-
-
-
-
630,
740
-
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
Tota
l C
FDA
No.
93.
071
95
-
-
-
-
-
95
-
Tota
l C
FDA
No.
93.
113
22
,939
-
-
-
-
-
22
,939
-
Tota
l C
FDA
No.
93.
136
-
-
-
-
105,
275
-
10
5,27
5
-
*
**
Uni
vers
ity O
f Illi
nois
At C
hica
go T
otal
15,7
04
-
-
-
-
-
15,7
04
-
Tota
l C
FDA
No.
93.
262
38
,992
-
-
-
-
-
38
,992
-
Tota
l C
FDA
No.
93.
RD
55,0
00
-
-
-
-
-
55,0
00
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Cen
ters
for D
isea
se C
ontr
ol a
nd P
reve
ntio
n
-50-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Dire
ct P
rogr
ams
by C
FDA
93.6
38A
CA
-Tra
nsfo
rmin
g C
linic
al P
ract
ice
Initi
ativ
e: P
ract
ice
Tran
sf
Net
wor
ks(P
TNs)
--
-
-
-
363,
083
-
36
3,08
3
-
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
Tota
l C
FDA
No.
93.
638
-
-
-
-
1,00
4,81
5
-
1,
004,
815
-
Tota
l C
FDA
No.
93.
778
-
-
-
-
1,62
2,89
0
-
1,
622,
890
-
Tot
al M
edic
aid
Clu
ster
-
-
-
-
1,62
2,89
0
-
1
,622
,890
-
Tota
l C
FDA
No.
93.
RD
343,
985
-
-
-
-
-
343,
985
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Cen
ters
for M
edic
are
and
Med
icai
d Se
rvic
es
Dire
ct P
rogr
ams
by C
FDA
93.1
03Fo
od a
nd D
rug
Adm
inis
tratio
n_R
esea
rch
-36
9,02
5
23
6,90
6
-
-
63,1
70
-
43
2,19
5
23
6,90
6
93.R
DU
.S. D
epar
tmen
t of H
ealth
& H
uman
Ser
vice
sH
HS
F223
2017
1013
7C90
,256
-
-
-
-
-
90
,256
-
93.U
00U
.S. D
epar
tmen
t of H
ealth
& H
uman
Ser
vice
sH
HS
F223
2016
1001
9C-
-
-
-
158,
450
-
15
8,45
0
-
93.U
01U
.S. D
epar
tmen
t of H
ealth
& H
uman
Ser
vice
sH
HS
F223
2014
1037
3A-
-
-
-
111,
939
-
11
1,93
9
-
93.U
04U
.S. D
epar
tmen
t of H
ealth
& H
uman
Ser
vice
sH
HS
F223
2017
1010
4C-
-
-
-
10,1
88
-
10
,188
-
93.U
05U
.S. D
epar
tmen
t of H
ealth
& H
uman
Ser
vice
sIP
A -
SA
ND
RA
BA
I-
-
-
-
30,0
24
-
30
,024
-
93.U
06U
.S. D
epar
tmen
t of H
ealth
& H
uman
Ser
vice
sIP
A -K
IER
STE
N W
ALT
ER
-
-
-
-
32
,600
-
32,6
00
-
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
-51-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
Nat
nl In
st fo
r Phr
mct
cl T
ech
& E
duc
Tot
al56
2,09
6
-
-
-
-
-
56
2,09
6
-
Tota
l C
FDA
No.
93.
103
1,
128,
690
-
-
-
10
5,62
7
-
1,23
4,31
7
-
*
**
Vin
ce a
nd A
ssoc
iate
s T
otal
109,
667
-
-
-
-
-
109,
667
-
Tota
l C
FDA
No.
93.
RD
109,
667
-
-
-
-
-
109,
667
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Foo
d an
d D
rug
Adm
inis
trat
ion
Dire
ct P
rogr
ams
by C
FDA
93.2
47A
dvan
ced
Edu
catio
n N
ursi
ng G
rant
Pro
gram
-35
3,62
0
-
-
-
16
1,17
9
-
514,
799
-
93.5
26A
fford
able
Car
e A
ct (A
CA
) Gra
nts
for C
apita
l Dev
elop
men
t in
Hea
lth
Cen
ters
--
-
-
-
779,
148
-
77
9,14
8
-
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
*
**
Indi
ana
Uni
vers
ity T
otal
95,8
04
3,50
0
-
-
-
-
95,8
04
3,50
0
Tota
l C
FDA
No.
93.
107
95
,804
3,
500
-
-
-
-
95
,804
3,
500
-52-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
93.
241
-
-
-
-
6,
343
-
6,
343
-
Tota
l C
FDA
No.
93.
359
1,
423
-
-
-
-
-
1,42
3
-
Tota
l C
FDA
No.
93.
912
27
,037
-
-
-
-
-
27
,037
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Hea
lth R
esou
rces
and
Ser
vice
s A
dmin
istr
atio
n
Dire
ct P
rogr
ams
by C
FDA
93.0
01C
ivil
Rig
hts
and
Priv
acy
Rul
e C
ompl
ianc
e A
ctiv
ities
-35
,380
-
-
-
-
-
35
,380
-
93.1
13B
iolo
gica
l Res
pons
e to
Env
ironm
enta
l Hea
lth H
azar
ds-
1,00
9,25
1
140,
004
-
-
-
-
1,
009,
251
14
0,00
4
93.1
21O
ral D
isea
ses
and
Dis
orde
rs R
esea
rch
-62
,323
-
-
-
-
-
62
,323
-
93.1
73R
esea
rch
Rel
ated
to D
eafn
ess
and
Com
mun
icat
ion
Dis
orde
rs-
4,11
4,70
3
59,8
52
-
-
-
-
4,
114,
703
59
,852
93.2
13R
esea
rch
and
Trai
ning
in C
ompl
emen
tary
and
Alte
rnat
ive
Med
icin
e-
840,
454
280,
387
-
-
-
-
84
0,45
4
28
0,38
7
93.2
42M
enta
l Hea
lth R
esea
rch
Gra
nts
-1,
197,
519
10
,325
-
-
-
-
1,19
7,51
9
10,3
25
93.2
73A
lcoh
ol R
esea
rch
Pro
gram
s-
314,
441
-
-
-
-
-
314,
441
-
93.2
79D
rug
Abu
se a
nd A
ddic
tion
Res
earc
h P
rogr
ams
-30
0,47
9
-
-
-
-
-
30
0,47
9
-
93.2
86D
isco
very
and
App
lied
Res
earc
h fo
r Tec
hnol
ogic
al In
nova
tions
to
Impr
ove
Hum
an H
e-
506,
516
182,
560
-
-
-
-
50
6,51
6
18
2,56
0
93.3
10Tr
ans-
NIH
Res
earc
h S
uppo
rt-
2,86
9,35
3
320,
130
-
-
-
-
2,
869,
353
32
0,13
0
93.3
51R
esea
rch
Infra
stru
ctur
e P
rogr
ams
-28
4,46
6
29
,802
-
-
-
-
284,
466
29,8
02
93.3
93C
ance
r Cau
se a
nd P
reve
ntio
n R
esea
rch
-1,
369,
164
31
9,18
4
-
-
-
-
1,36
9,16
4
319,
184
93.3
95C
ance
r Tre
atm
ent R
esea
rch
-3,
364,
472
23
2,62
7
-
-
-
-
3,36
4,47
2
232,
627
93.3
96C
ance
r Bio
logy
Res
earc
h-
880,
496
8,09
2
-
-
-
-
880,
496
8,09
2
93.3
97C
ance
r Cen
ters
Sup
port
Gra
nts
-2,
101,
943
13
1,76
3
-
-
-
-
2,10
1,94
3
131,
763
-53-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
93.3
98C
ance
r Res
earc
h M
anpo
wer
-36
4,41
5
22
0,08
3
-
-
-
-
364,
415
220,
083
93.8
37H
eart
and
Vas
cula
r Dis
ease
s R
esea
rch
-1,
746,
295
40
7,95
5
-
-
-
-
1,74
6,29
5
407,
955
93.8
39B
lood
Dis
ease
s an
d R
esou
rces
Res
earc
h-
216,
939
-
-
-
-
-
216,
939
-
93.8
46A
rthrit
is, M
uscu
losk
elet
al a
nd S
kin
Dis
ease
s R
esea
rch
-86
7,47
1
2,
078
-
-
-
-
86
7,47
1
2,
078
93.8
47D
iabe
tes,
End
ocrin
olog
y an
d M
etab
olis
m R
esea
rch
-2,
168,
250
12
9,76
9
-
-
-
-
2,16
8,25
0
129,
769
93.8
53E
xtra
mur
al R
esea
rch
Pro
gram
s in
the
Neu
rosc
ienc
es a
nd
Neu
rolo
gica
l Dis
orde
rs-
1,04
6,26
1
106,
522
-
-
-
-
1,
046,
261
10
6,52
2
93.8
55A
llerg
y, Im
mun
olog
y an
d Tr
ansp
lant
atio
n R
esea
rch
-6,
032,
366
1,
100,
934
-
-
-
-
6,03
2,36
6
1,10
0,93
4
93.8
59B
iom
edic
al R
esea
rch
and
Res
earc
h Tr
aini
ng-
8,06
3,75
9
237,
255
-
-
-
-
8,
063,
759
23
7,25
5
93.8
65C
hild
Hea
lth a
nd H
uman
Dev
elop
men
t Ext
ram
ural
Res
earc
h-
1,09
7,03
5
107,
561
-
-
-
-
1,
097,
035
10
7,56
1
93.8
66A
ging
Res
earc
h-
602,
559
38,7
54
-
-
-
-
60
2,55
9
38
,754
93.8
67V
isio
n R
esea
rch
-54
5,38
1
-
-
-
-
-
54
5,38
1
-
93.8
79M
edic
al L
ibra
ry A
ssis
tanc
e-
84,1
73
10,5
18
-
-
-
-
84
,173
10
,518
93.9
89In
tern
atio
nal R
esea
rch
and
Res
earc
h Tr
aini
ng-
137,
484
45,1
33
-
-
-
-
13
7,48
4
45
,133
93.R
DU
.S. D
epar
tmen
t of H
ealth
& H
uman
Ser
vice
sB
EC
K8,
391
-
-
-
-
-
8,39
1
-
D13
PX
0015
494
,648
-
-
-
-
-
94
,648
-
IP15
1208
799,
992
-
-
-
-
-
9,99
2
-
*
**
93.R
D T
otal
113,
031
-
-
-
-
-
113,
031
-
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
Tota
l C
FDA
No.
93.
113
62
,865
-
-
-
-
-
62
,865
-
Tota
l C
FDA
No.
93.
143
76
,048
-
-
-
-
-
76
,048
-
-54-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
93.
173
91
,297
-
-
-
-
-
91
,297
-
Tota
l C
FDA
No.
93.
242
21
7,16
7
-
-
-
-
-
21
7,16
7
-
Tota
l C
FDA
No.
93.
273
14
2,70
1
-
-
-
-
-
14
2,70
1
-
Tota
l C
FDA
No.
93.
279
14
0,94
0
-
-
-
-
-
14
0,94
0
-
Tota
l C
FDA
No.
93.
286
11
5,69
9
-
-
-
-
-
11
5,69
9
-
-55-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
In U
niv
Pur
due
Uni
v A
t Ind
iana
polis
Tot
al1,
032,
580
-
-
-
-
-
1,
032,
580
-
*
**
Indi
ana
Uni
vers
ity T
otal
146,
145
-
-
-
-
-
146,
145
-
Tota
l C
FDA
No.
93.
350
1,
179,
068
-
-
-
-
-
1,
179,
068
-
Tota
l C
FDA
No.
93.
393
38
,840
-
-
-
-
-
38
,840
-
Tota
l C
FDA
No.
93.
394
24
7,69
1
-
-
-
-
-
24
7,69
1
-
Tota
l C
FDA
No.
93.
396
43
0,81
9
-
-
-
-
-
43
0,81
9
-
*
**
Mou
nt S
inai
Sch
ool O
f Med
icin
e T
otal
22,6
11
-
-
-
-
-
22,6
11
-
Tota
l C
FDA
No.
93.
837
64
,475
-
-
-
-
-
64
,475
-
-56-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
93.
846
20
5,10
7
-
-
-
-
-
20
5,10
7
-
Tota
l C
FDA
No.
93.
847
15
8,94
5
-
-
-
-
-
15
8,94
5
-
*
**
Yal
e U
nive
rsity
Tot
al10
7,81
4
-
-
-
-
-
10
7,81
4
-
Tota
l C
FDA
No.
93.
853
14
3,31
4
-
-
-
-
-
14
3,31
4
-
*
**
Texa
s A
&M
Res
earc
h Fo
unda
tion
Tot
al27
,683
-
-
-
-
-
27
,683
-
-57-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
Was
hing
ton
Uni
vers
ity T
otal
525,
718
-
-
-
-
-
525,
718
-
Tota
l C
FDA
No.
93.
855
1,
684,
056
-
-
-
-
-
1,
684,
056
-
Tota
l C
FDA
No.
93.
859
1,
001,
366
-
-
-
-
-
1,
001,
366
-
Tota
l C
FDA
No.
93.
865
38
,825
-
-
-
-
-
38
,825
-
-58-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
93.
866
(1
6,48
9)
-
-
-
-
-
(16,
489)
-
*
**
Cor
nell
Uni
vers
ity T
otal
56,1
18
-
-
-
-
-
56,1
18
-
Tota
l C
FDA
No.
93.
867
56
,118
-
-
-
-
-
56
,118
-
Tota
l C
FDA
No.
93.
989
56
,241
-
-
-
-
-
56
,241
-
*
**
Pac
ific
Nor
thw
est N
atio
nal L
abor
ator
y T
otal
74,4
24
-
-
-
-
-
74,4
24
-
Tota
l C
FDA
No.
93.
RD
320,
793
-
-
-
-
-
320,
793
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Nat
iona
l Ins
titut
e of
Hea
lth
Dire
ct P
rogr
ams
by C
FDA
93.1
36In
jury
Pre
vent
ion
and
Con
trol R
esea
rch
and
Sta
te a
nd C
omm
unity
B
ased
Pro
gram
s-
285,
519
57,4
92
-
-
-
-
28
5,51
9
57
,492
-59-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
93.U
07U
.S. D
epar
tmen
t of H
ealth
& H
uman
Ser
vice
sD
hhs
Pha
rmac
y Lo
an-
-
-
-
69
-
69
-
93.U
08U
.S. D
epar
tmen
t of H
ealth
& H
uman
Ser
vice
sD
hhs
Vet
Med
Loa
n-
-
-
-
1,60
3
-
1,60
3
-
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
Tota
l C
FDA
No.
93.
136
16
,301
-
-
-
-
-
16
,301
-
Tota
l C
FDA
No.
93.
241
-
-
-
-
83,0
71
-
83
,071
-
*
**
Hea
lth C
are
Edu
catio
n-Tr
aini
ng In
c T
otal
-
-
-
-
36
,017
-
36,0
17
-
Tota
l C
FDA
No.
93.
297
-
-
-
-
36,0
17
-
36
,017
-
Tota
l C
FDA
No.
93.
945
10
,350
-
-
-
-
-
10
,350
-
Tota
l C
FDA
No.
93.
959
56,8
67
-
-
-
-
-
56,8
67
-
Tota
l C
FDA
No.
93.
RD
65,5
97
-
-
-
-
-
65,5
97
-
Tota
l C
FDA
No.
93.
U02
-
-
-
-
9,25
0
-
9,25
0
-
Tota
l C
FDA
No.
93.
U03
-
-
-
-
46,6
32
-
46
,632
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Oth
er D
HH
S A
genc
ies
-60-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l Dep
artm
ent o
f Hea
lth a
nd H
uman
Ser
vice
s D
irect
Pro
gram
s
Tota
l Dep
artm
ent o
f Hea
lth a
nd H
uman
Ser
vice
s Pa
ss-T
hrou
gh G
rant
ors
Tota
l Dep
artm
ent o
f Hea
lth a
nd H
uman
Ser
vice
s
Dire
ct P
rogr
ams
by C
FDA
*
**
97.R
D T
otal
235,
622
68,7
41
-
-
-
-
23
5,62
2
68
,741
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
*
**
Nor
thea
ster
n U
nive
rsity
Tot
al37
9,59
9
-
-
-
56
,995
-
436,
594
-
Tota
l C
FDA
No.
97.
061
48
1,76
0
-
-
-
56
,995
-
538,
755
-
*
**
Nor
thea
ster
n U
nive
rsity
Tot
al22
3,03
9
-
-
-
-
-
22
3,03
9
-
Tota
l C
FDA
No.
97.
RD
292,
693
-
-
-
-
-
292,
693
-
Tota
l Pas
s-Th
roug
h G
rant
ors
-61-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l Dep
artm
ent o
f Hom
elan
d Se
curit
y
Dire
ct P
rogr
ams
by C
FDA
Tota
l Dire
ct P
rogr
ams
Pas
s-Th
roug
h G
rant
ors
by C
FDA
*
**
Kan
sas
Sta
te U
nive
rsity
Tot
al-
-
-
-
737,
486
57
,111
737,
486
57,1
11
*
**
Nat
iona
l Aca
dem
y O
f Sci
ence
s T
otal
-
-
-
-
58
,176
-
58,1
76
-
Tota
l C
FDA
No.
98.
001
37
,544
-
-
-
1,
523,
745
465,
207
1,
561,
289
46
5,20
7
-62-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Tota
l C
FDA
No.
98.
012
-
-
-
-
1,10
5,39
5
-
1,
105,
395
-
*
**
Nat
iona
l Aca
dem
y O
f Sci
ence
s T
otal
113,
719
-
-
-
-
-
113,
719
-
Tota
l C
FDA
No.
98.
RD
118,
550
-
-
-
-
-
118,
550
-
Tota
l C
FDA
No.
98.
U01
-
-
-
-
176,
775
28
,970
176,
775
28,9
70
Tota
l C
FDA
No.
98.
U02
-
-
-
-
5,84
9
-
5,84
9
-
Tota
l C
FDA
No.
98.
U03
-
-
-
-
4,25
7
-
4,25
7
-
Tota
l C
FDA
No.
98.
U04
-
-
-
-
12,0
00
-
12
,000
-
Tota
l Pas
s-Th
roug
h G
rant
ors
Tota
l Age
ncy
for I
nter
natio
nal D
evel
opm
ent
Dire
ct P
rogr
ams
by C
FDA
Tota
l Dire
ct P
rogr
ams
Tota
l Cen
tral
Inte
llige
ncy
Age
ncy
Dire
ct P
rogr
ams
by C
FDA
-63-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
*
**
99.R
D T
otal
430,
953
-
-
-
-
-
430,
953
-
Tota
l Dire
ct P
rogr
ams
Tota
l Dep
artm
ent o
f Vet
eran
's A
ffairs
Dire
ct P
rogr
ams
by C
FDA
Tota
l Dire
ct P
rogr
ams
Tota
l Uni
ted
Stat
es In
tern
atio
nal T
rade
Com
mis
sion
Sum
mar
y of
Dire
ct P
rogr
ams
-64-
CFD
AId
entif
ying
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Fede
ral A
war
dsEx
pend
iture
s to
Gra
ntor
No.
CFD
A Ti
tle/P
ass-
Thro
ugh
Gra
ntor
Num
ber
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Expe
nded
Subr
ecip
ient
sEx
pend
edSu
brec
ipie
nts
Rese
arch
and
Dev
elop
men
tSt
uden
t Fin
anci
al A
ssist
ance
*O
ther
Tota
l
Sum
mar
y of
Pas
s-Th
roug
h G
rant
ors
Sum
mar
y of
Tot
al F
eder
al A
war
ds
-65-
Section I - Summary of Auditor's Results
Section II - Financial Statement Findings
Section III - Federal Award Findings and Questioned Costs
FINDING
Condition
Context
Criteria
General
Excess cash tolerance.
Consequences for maintaining excess cash.
Cause
Effect
Questioned Costs
Recommendation
Views of Responsible Officials
CORRECTIVE ACTION PLAN FINDING 2018-001 Contact Person Responsible for Corrective Action: Kimberly Thomas, Purdue Northwest Associate Vice Chancellor of Finance and Business Services or Peg Fish, Director of Audits Contact Phone Number: Kimberly Thomas (219)-989-2853 Peg Fish (765)-494-7588 View of the Responsible Official: The University concurs with the finding that enhancements to Purdue NorthWest cash management are necessary. A single error of $191,402, out of total draws of $35,126,833 (.54%), occurred. Description of Corrective Action Plan: While a reconciliation process was in place during the audit period, it was not designed effectively for timely detection of the error that occurred. The Purdue Northwest campus detected the excess cash and reduced the draw request on May 17, 2018. As noted in Finding 2018-001, the amount of excess cash held remained below the one-percent tolerance. Cash management processes have been modified to enhance the effectiveness of the control for detecting excess cash positions. The following corrective actions have been implemented to ensure cash management compliance. The backup documentations for draws will be reviewed by the Senior Accountant before any draws are initiated. The focus of this review will be on the current cash balance in SAP to ensure draws do not occur when a positive cash balance is maintained. A monthly reconciliation will be prepared by the Senior Accountant instead of the Staff Accountant that had previously prepared them, ensuring separation of duties. Reconciliations will document activity on a daily basis instead of focusing on month end balances. These reconciliations will compare the data from the Banner, SAP and G5 systems to ensure consistency throughout. After completion the reconciliation will be forwarded to the Director of Financial Accounting & Reporting for additional review. Anticipated Completion Date: March 6th, 2019
-74-
